EFGR mutation
Xem 1-1 trên 1 kết quả EFGR mutation
-
Recent reports suggested combining ramucirumab with epidermal growth factor receptor (EGFR)- tyrosine kinase inhibitors (TKIs) to overcome EGFR resistance in non–small cell lung cancer (NSCLC).
8p visharma 20-10-2023 3 2 Download
CHỦ ĐỀ BẠN MUỐN TÌM
TOP DOWNLOAD